Diabetic Live

According to a study at the Henry Ford Hospital in Detroit, a group of medications that lowers blood sugar in diabetic patients is also helping to protect them against heart failure as well.

Henry Ford researcher and cardiologist David Lanfear, M.D., lead author of the study said, “People with diabetes are at risk for developing heart failure. Diabetic adults die of heart disease two to four times more than those without diabetes.

Continue reading “Type 2 Diabetes Drug Class Reducing Heart Failure”

A common anti-anginal drug has been found to reduce the chest pain that many people with type 2 diabetes suffer from. According to research that was presented to the American College of Cardiology’s 62^nd Annual Scientific Session., the drug also appears to have a more pronounced effect with those who have poorer glucose control.

Continue reading “New Type 2 Diabetes Drug Found To Reduce Chest Pain”

New Jersey Institute for Successful Aging (NJISA) at the University of Medicine and Dentistry of New Jersey (UMDNJ)-School of Osteopathic Medicine’s Robert Nagele, PhD, led a research team that has demonstrated that the anti-atherosclerosis drug darapladib can reduce leaks in the blood brain barrier. These findings open up quite a few possibilities for new drug therapies to prevent the onset of Alzheimer’s disease.

The researchers were able to find this new drug theory through an a study that involved the use of darapladib in animal models that had been stimulated to develop diabetes mellitus and hypercholesterolemia (DMHC), which are both huge risk factors for developing Alzheimer’s disease.

Continue reading “New Diabetic Study Shows Drug Can Slow Alzheimer’s Disease”

According to new research, those who are taking the newest class of diabetic drugs in order to control blood sugar are more likely to become hospitalized with pancreatitis.

Scientists say that the glucagon-like peptide-1-based therapies (GLP-1) of the new drugs is the culprit for the increased risk of hospitalization for acute pancreatitis. Sitagliptin (brand named Janivia) and Extenatide (brand named Byetta) are suggested to contribute to the formation of lesions within the pancreas and the introductions of ducts in the organ. This causes an increased amount of inflammation.

Continue reading “Type 2 Diabetes Medications Causing Pancreatitis”

A trial was conducted by IRCM researchers (led by endocrinologist Dr. Rémi Rabasa-Lhoret) that compared a dual-hormone artificial pancreas with conventional diabetes treatments that use an insulin pump and showed improved glucose levels and lower risks of hypoglycemia.

The results showed that the artificial pancreas can have a huge impact where treatment is concerned for people who have been diagnosed with type 1 diabetes.

Continue reading “Trial Results In On New Artificial Pancreas”

Diabetes itself is growing. It has been for years now. What surprises many people however is to learn that type 1 diabetes among children is growing at a higher rate. In fact, in children aged under five years old, type 1 diabetes has increased by 70 percent in Philadelphia.

Information about diabetes has been collected since 1985 from the University of Pennsylvania.  Researchers led by nursing professor Terri H. Lipman, PhD, RN found that there was an increase in type 1 diabetes in children of 29 percent between the years of 1985 and 2004.

Continue reading “Type 1 Diabetes Has Increased in Urban Children By 70 Percent”

Studies show that every 30 seconds someone around the world will lose their foot through amputation due to diabetic complications. According to a study by Sahlgrenska Academy in the University of Gathenburg, Sweden shows that just a few routine tips and techniques could cut down on the need for amputations by 50 percent.

These tips and techniques include regular check-ups from a doctor and wearing correct inserts and other necessary changes deemed warranted by a podiatrist.

Continue reading “Study Shows 50% Reduction In Amputations Among Diabetics”

A little more than a century ago, diabetes was looked at as a fatal long-term illness. Today however, thanks to the discovery of insulin, it is looked at more as a chronic disease and due to many medical discoveries in medicine; there are many ways to make diabetes less of a struggle.

A team, which included researchers from Case Western Reserve University School of Medicine released information about their study and what they had discovered, which could lead to remarkable developments in patients who are trying to manage diabetes.

Continue reading “New Research Shows How Insulin Reacts With Cells”